multiplexed sample: Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 87 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 87 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (male, 89 years) substantia nigra tissue; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 87 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (male, 89 years) substantia nigra tissue; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 87 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (male, 89 years) substantia nigra tissue; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (male, 89 years) substantia nigra tissue; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 87 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (male, 89 years) substantia nigra tissue; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (male, 89 years) substantia nigra tissue; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 87 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 87 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (male, 89 years) substantia nigra tissue; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (male, 89 years) substantia nigra tissue; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; Homo sapiens (male, 87 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples